Thanks for the explanation, Ken. The news and accompanying speculation is coming so fast I sometimes lose track of what's being posted. In the same vein I get confused by the alphabet soup and jargon of biotech and cancer research specifically. All clarifications are appreciated, as we educate ourselves and, hopefully, become better advocates and investors.